Adaptive Biotechnologies ...

NASDAQ: ADPT · Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.04
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT

Adaptive Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
47.92M 65.06M 90.03M 139.06M
Short-Term Investments
174.37M 281.34M 408.17M 214M
Long-Term Investments
33.66M n/a 2.4M 217.15M
Other Long-Term Assets
5.18M 6.52M 4.46M 3.01M
Receivables
41.73M 37.97M 40.06M 17.41M
Inventory
8.44M 14.45M 14.45M 19.26M
Other Current Assets
11.29M 11.37M 9.44M 1.4M
Total Current Assets
283.75M 410.19M 562.15M 402.75M
Property-Plant & Equipment
94.38M 120.32M 164.21M 172.94M
Goodwill & Intangibles
122.4M 124.1M 125.8M 127.5M
Total Long-Term Assets
255.62M 250.95M 294.47M 520.6M
Total Assets
539.38M 661.13M 856.62M 923.34M
Account Payables
7.26M 7.72M 8.08M 3.31M
Deferred Revenue
55.69M 48.63M 64.11M 80.46M
Short-Term Debt
n/a 5.09M 9.23M 5.05M
Other Current Liabilities
35.1M 13.69M 6.71M 10.59M
Total Current Liabilities
98.05M 88.02M 109.79M 113.81M
Long-Term Debt
132.41M 130.66M n/a n/a
Other Long-Term Liabilities
238.84M n/a 125.36M n/a
Total Long-Term Liabilities
238.84M 264.84M 282.73M 205.44M
Total Liabilities
336.89M 352.86M 392.52M 319.24M
Total Debt
89.39M 229.43M 108M 111.74M
Common Stock
14K 14K 14K 14K
Retained Earnings
-1.3B -1.14B -919.08M -718.89M
Comprehensive Income
n/a 215K -4.12M -1.14M
Shareholders Equity
202.71M 308.4M 464.17M 603.99M
Total Investments
208.03M 281.34M 408.17M 431.14M